183 related articles for article (PubMed ID: 27065461)
1. Use of 3-Dimensional Volumetric Modeling of Adrenal Gland Size in Patients with Primary Pigmented Nodular Adrenocortical Disease.
Chrysostomou PP; Lodish MB; Turkbey EB; Papadakis GZ; Stratakis CA
Horm Metab Res; 2016 Apr; 48(4):242-6. PubMed ID: 27065461
[TBL] [Abstract][Full Text] [Related]
2. Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).
Vezzosi D; Tenenbaum F; Cazabat L; Tissier F; Bienvenu M; Carrasco CA; Laloi-Michelin M; Barrande G; Lefebvre H; Hiéronimus S; Tabarin A; Bertagna X; Legmann P; Vantyghem MC; Bertherat J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4332-8. PubMed ID: 26390100
[TBL] [Abstract][Full Text] [Related]
3. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
[TBL] [Abstract][Full Text] [Related]
4. ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.
Maria AG; Tatsi C; Berthon A; Drougat L; Settas N; Hannah-Shmouni F; Bertherat J; Faucz FR; Stratakis CA
Endocr Relat Cancer; 2020 Sep; 27(9):509-517. PubMed ID: 32638579
[TBL] [Abstract][Full Text] [Related]
5. Detection of new potentially pathogenic mutations in two patients with primary pigmented nodular adrenocortical disease (PPNAD) - case reports with literature review.
Pasternak-Pietrzak K; Stratakis CA; Moszczyńska E; Lecka-Ambroziak A; Staniszewski M; Wątrobińska U; Lyssikatos C; Prokop-Piotrkowska M; Grajkowska W; Pronicki M; Szalecki M
Endokrynol Pol; 2018; 69(6):675-681. PubMed ID: 30259502
[TBL] [Abstract][Full Text] [Related]
6. An unusual presentation of Carney complex with diffuse primary pigmented nodular adrenocortical disease on one adrenal gland and a nonpigmented adrenocortical adenoma and focal primary pigmented nodular adrenocortical disease on the other.
Tung SC; Hwang DY; Yang JW; Chen WJ; Lee CT
Endocr J; 2012; 59(9):823-30. PubMed ID: 22785148
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
[TBL] [Abstract][Full Text] [Related]
8. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L; Ragazzon B; Groussin L; Bertherat J
Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
[TBL] [Abstract][Full Text] [Related]
9. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.
Storr HL; Mitchell H; Swords FM; Main KM; Hindmarsh PC; Betts PR; Shaw NJ; Johnston DI; Clark AJ; Reznek RH; Grossman AB; Savage MO
Clin Endocrinol (Oxf); 2004 Nov; 61(5):553-9. PubMed ID: 15521956
[TBL] [Abstract][Full Text] [Related]
10. Children with Cushing's syndrome: Primary Pigmented Nodular Adrenocortical Disease should always be suspected.
da Silva RM; Pinto E; Goldman SM; Andreoni C; Vieira TC; Abucham J
Pituitary; 2011 Mar; 14(1):61-7. PubMed ID: 20924687
[TBL] [Abstract][Full Text] [Related]
11. Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications.
London E; Rothenbuhler A; Lodish M; Gourgari E; Keil M; Lyssikatos C; de la Luz Sierra M; Patronas N; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2014 Feb; 99(2):E303-10. PubMed ID: 24248186
[TBL] [Abstract][Full Text] [Related]
12. PRKAR1A-negative familial Cushing's syndrome: two case reports.
Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
[TBL] [Abstract][Full Text] [Related]
13. Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
Hofland J; de Herder WW; Derks L; Hofland LJ; van Koetsveld PM; de Krijger RR; van Nederveen FH; Horvath A; Stratakis CA; de Jong FH; Feelders RA
Eur J Endocrinol; 2013 Jan; 168(1):67-74. PubMed ID: 23065993
[TBL] [Abstract][Full Text] [Related]
14. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
[TBL] [Abstract][Full Text] [Related]
15. [Primary pigmented nodular adrenocortical dysplasia (PPNAD) within the scope of Carney complex as the etiology of Cushing syndrome].
Koch CA; Bornstein SR; Chrousos GP; Stratakis CA
Med Klin (Munich); 2000 Apr; 95(4):224-30. PubMed ID: 10808306
[TBL] [Abstract][Full Text] [Related]
16. Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.
Sahut-Barnola I; de Joussineau C; Val P; Lambert-Langlais S; Damon C; Lefrançois-Martinez AM; Pointud JC; Marceau G; Sapin V; Tissier F; Ragazzon B; Bertherat J; Kirschner LS; Stratakis CA; Martinez A
PLoS Genet; 2010 Jun; 6(6):e1000980. PubMed ID: 20548949
[TBL] [Abstract][Full Text] [Related]
17. Primary pigmented nodular adrenocortical disease (PPNAD): single centre experience.
Memon SS; Thakkar K; Patil V; Jadhav S; Lila AR; Fernandes G; Bandgar TR; Shah NS
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):391-397. PubMed ID: 30875328
[TBL] [Abstract][Full Text] [Related]
18. A rare case of familial Cushing's syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease.
Poukoulidou T; Maiter D; Bertherat J; Beauloye V
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):1005-9. PubMed ID: 24859511
[TBL] [Abstract][Full Text] [Related]
19. A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer.
Anselmo J; Medeiros S; Carneiro V; Greene E; Levy I; Nesterova M; Lyssikatos C; Horvath A; Carney JA; Stratakis CA
J Clin Endocrinol Metab; 2012 Feb; 97(2):351-9. PubMed ID: 22112814
[TBL] [Abstract][Full Text] [Related]
20. Diurnal Plasma Cortisol Measurements Utility in Differentiating Various Etiologies of Endogenous Cushing Syndrome.
Tirosh A; Lodish MB; Papadakis GZ; Lyssikatos C; Belyavskaya E; Stratakis CA
Horm Metab Res; 2016 Sep; 48(10):677-681. PubMed ID: 27643448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
